Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AstraZeneca | 5.01% | $242.65K | $285.76B | 37.40% | 79 Outperform | |
| HOYA | 4.94% | $239.35K | ¥8.16T | 16.63% | 74 Outperform | |
| ASML Holding NV | 4.71% | $228.05K | €344.40B | 31.20% | 76 Outperform | |
| Mercadolibre | 4.21% | $203.76K | $101.27B | 15.25% | 77 Outperform | |
| Nomura Research Institute | 4.16% | $201.37K | ¥3.51T | 30.48% | 74 Outperform | |
| Ferrari | 3.83% | $185.74K | $89.86B | -12.76% | 72 Outperform | |
| ― | 3.62% | $175.17K | ― | ― | ― | |
| Air Liquide | 3.55% | $171.83K | €92.08B | 3.30% | 66 Neutral | |
| Mastercard | 3.45% | $167.09K | $513.86B | 8.84% | 75 Outperform | |
| Lonza Group Ltd | 3.25% | $157.33K | CHF36.40B | -0.15% | 71 Outperform |